133 related articles for article (PubMed ID: 26743104)
41. Risk Factors for Childhood Leukemia: Radiation and Beyond.
Schmidt JA; Hornhardt S; Erdmann F; Sánchez-García I; Fischer U; Schüz J; Ziegelberger G
Front Public Health; 2021; 9():805757. PubMed ID: 35004601
[TBL] [Abstract][Full Text] [Related]
42. An isolated childhood myeloid sarcoma with germline MSH6 mutation-a case report.
Liu Y; GuLiBaHa M; Yue YB; Li MW; Cao SB; Yan M
Transl Pediatr; 2021 Aug; 10(8):2136-2143. PubMed ID: 34584885
[TBL] [Abstract][Full Text] [Related]
43. Lymphoblastic lymphoma in two young siblings (coincidence or genetics?): two case reports.
Hassan NT; Makhoul E; Sallameh J; Ghanem A; Rajab S; Ali W; Alshehabi Z
J Med Case Rep; 2021 Jul; 15(1):375. PubMed ID: 34315532
[TBL] [Abstract][Full Text] [Related]
44. Implications of ACMG guidelines to identify high-risk acute lymphoblastic leukemia patients with hereditary cancer susceptibility syndromes (HCSS) in a highly consanguineous population.
Aslam S; Shabana ; Ahmed M
BMC Pediatr; 2021 Jun; 21(1):282. PubMed ID: 34134655
[TBL] [Abstract][Full Text] [Related]
45. Toward prevention of childhood ALL by early-life immune training.
Hauer J; Fischer U; Borkhardt A
Blood; 2021 Oct; 138(16):1412-1428. PubMed ID: 34010407
[TBL] [Abstract][Full Text] [Related]
46. Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients.
Shin SY; Lee H; Lee ST; Choi JR; Jung CW; Koo HH; Kim SH
Sci Rep; 2021 Apr; 11(1):8893. PubMed ID: 33903686
[TBL] [Abstract][Full Text] [Related]
47. Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.
van Engelen N; van Dijk F; Waanders E; Buijs A; Vermeulen MA; Loeffen JLC; Kuiper RP; Jongmans MCJ
Fam Cancer; 2021 Oct; 20(4):349-354. PubMed ID: 33811277
[TBL] [Abstract][Full Text] [Related]
48. Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms.
Mosquera Orgueira A; Cid López M; Peleteiro Raíndo A; Díaz Arias JÁ; Antelo Rodríguez B; Bao Pérez L; Alonso Vence N; Bendaña López Á; Abuin Blanco A; Melero Valentín P; Ferreiro Ferro R; Aliste Santos C; Fraga Rodríguez MF; González Pérez MS; Pérez Encinas MM; Bello López JL
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809641
[TBL] [Abstract][Full Text] [Related]
49. DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns.
Sharma R; Lewis S; Wlodarski MW
Front Pediatr; 2020; 8():570084. PubMed ID: 33194896
[TBL] [Abstract][Full Text] [Related]
50. Germline variants of DNA repair genes in early onset mantle cell lymphoma.
Wang X; Song Y; Chen W; Ding N; Liu W; Xie Y; Wang Y; Zhu J; Zeng C
Oncogene; 2021 Jan; 40(3):551-563. PubMed ID: 33191405
[TBL] [Abstract][Full Text] [Related]
51. Compound Heterozygous Variants in Pediatric Cancers: A Systematic Review.
Miller DB; Piccolo SR
Front Genet; 2020; 11():493. PubMed ID: 32508881
[TBL] [Abstract][Full Text] [Related]
52. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A; Carraro E; Ronceray L; Andrés M; Barzilai-Birenboim S; Bomken S; Brugières L; Burkhardt B; Ceppi F; Chiang AKS; Csoka M; Fedorova A; Jazbec J; Kabickova E; Loeffen J; Mellgren K; Miakova N; Moser O; Osumi T; Pourtsidis A; Rigaud C; Uyttebroeck A; Woessmann W; Pillon M;
Leukemia; 2021 Feb; 35(2):534-549. PubMed ID: 32393843
[TBL] [Abstract][Full Text] [Related]
53. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group.
Moser O; Zimmermann M; Meyer U; Klapper W; Oschlies I; Schrappe M; Attarbaschi A; Mann G; Niggli F; Spix C; Kontny U; Klingebiel T; Reiter A; Burkhardt B; Woessmann W
Haematologica; 2021 May; 106(5):1390-1400. PubMed ID: 32299903
[TBL] [Abstract][Full Text] [Related]
54. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia.
Bloom M; Maciaszek JL; Clark ME; Pui CH; Nichols KE
Expert Rev Hematol; 2020 Jan; 13(1):55-70. PubMed ID: 31657974
[No Abstract] [Full Text] [Related]
55. Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1
Gladbach YS; Wiegele L; Hamed M; Merkenschläger AM; Fuellen G; Junghanss C; Maletzki C
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581674
[TBL] [Abstract][Full Text] [Related]
56. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
57. B-cell acute lymphoblastic leukemia with high mutation burden presenting in a child with constitutional mismatch repair deficiency.
Oshrine B; Grana N; Moore C; Nguyen J; Crenshaw M; Edwards M; Sudhaman S; Forster VJ; Tabori U
Blood Adv; 2019 Jun; 3(12):1795-1798. PubMed ID: 31189528
[TBL] [Abstract][Full Text] [Related]
58. CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report.
Ding C; Huang Y; Shi M; Nie B; Li Y; Wu K; Yang J; Zeng Y
Medicine (Baltimore); 2019 Apr; 98(15):e15204. PubMed ID: 30985716
[TBL] [Abstract][Full Text] [Related]
59. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
[TBL] [Abstract][Full Text] [Related]
60. DNA damage response and hematological malignancy.
Takagi M
Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
